Quantitative profiling of 25 genes encoding proteoglycans revealed that specific transcripts, including LUM and SRGN, exhibit significantly higher counts in the viable region of the GBM sample (Supplementary Fig. 5E, F). This evidence concerns the gene LUM and glioblastoma.